These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28594651)

  • 1. miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling.
    Pekow J; Hutchison AL; Meckel K; Harrington K; Deng Z; Talasila N; Rubin DT; Hanauer SB; Hurst R; Umanskiy K; Fichera A; Hart J; Dinner AR; Bissonnette M
    Inflamm Bowel Dis; 2017 Aug; 23(8):1328-1337. PubMed ID: 28594651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD.
    Pekow J; Meckel K; Dougherty U; Huang Y; Chen X; Almoghrabi A; Mustafi R; Ayaloglu-Butun F; Deng Z; Haider HI; Hart J; Rubin DT; Kwon JH; Bissonnette M
    Clin Cancer Res; 2017 Sep; 23(17):5281-5291. PubMed ID: 28600480
    [No Abstract]   [Full Text] [Related]  

  • 3. A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer.
    Chacon-Millan P; Lama S; Del Gaudio N; Gravina AG; Federico A; Pellegrino R; Luce A; Altucci L; Facchiano A; Caraglia M; Stiuso P
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions.
    Pekow J; Dougherty U; Huang Y; Gometz E; Nathanson J; Cohen G; Levy S; Kocherginsky M; Venu N; Westerhoff M; Hart J; Noffsinger AE; Hanauer SB; Hurst RD; Fichera A; Joseph LJ; Liu Q; Bissonnette M
    Inflamm Bowel Dis; 2013 Mar; 19(3):461-70. PubMed ID: 23388545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
    Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
    Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis.
    Van der Goten J; Vanhove W; Lemaire K; Van Lommel L; Machiels K; Wollants WJ; De Preter V; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Schuit F; Vermeire S; Arijs I
    PLoS One; 2014; 9(12):e116117. PubMed ID: 25546151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-Specific MicroRNA Expression May Lead to Different Subtypes in Ulcerative Colitis.
    Ranjha R; Aggarwal S; Bopanna S; Ahuja V; Paul J
    PLoS One; 2015; 10(11):e0142869. PubMed ID: 26569605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis.
    Benderska N; Dittrich AL; Knaup S; Rau TT; Neufert C; Wach S; Fahlbusch FB; Rauh M; Wirtz RM; Agaimy A; Srinivasan S; Mahadevan V; Rümmele P; Rapti E; Gazouli M; Hartmann A; Schneider-Stock R
    Inflamm Bowel Dis; 2015 Sep; 21(9):2039-51. PubMed ID: 26083618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis.
    Dubois-Camacho K; Diaz-Jimenez D; De la Fuente M; Quera R; Simian D; Martínez M; Landskron G; Olivares-Morales M; Cidlowski JA; Xu X; Gao G; Xie J; Chnaiderman J; Soto-Rifo R; González MJ; Calixto A; Hermoso MA
    Front Immunol; 2019; 10():2449. PubMed ID: 31824476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-370-3p Alleviates Ulcerative Colitis-Related Colorectal Cancer in Mice Through Inhibiting the Inflammatory Response and Epithelial-Mesenchymal Transition.
    Lin L; Wang D; Qu S; Zhao H; Lin Y
    Drug Des Devel Ther; 2020; 14():1127-1141. PubMed ID: 32214798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
    Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
    Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-155 is involved in the pathogenesis of ulcerative colitis by targeting FOXO3a.
    Min M; Peng L; Yang Y; Guo M; Wang W; Sun G
    Inflamm Bowel Dis; 2014 Apr; 20(4):652-9. PubMed ID: 24583476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer.
    Xiong Y; Zhang L; Holloway AK; Wu X; Su L; Kebebew E
    PLoS One; 2011; 6(10):e24717. PubMed ID: 21998631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of microRNA-222-3p ameliorates ulcerative colitis and colitis-associated colorectal cancer to protect against oxidative stress
    Wang XJ; Zhang D; Yang YT; Li XY; Li HN; Zhang XP; Long JY; Lu YQ; Liu L; Yang G; Liu J; Hong J; Wu HG; Ma XP
    Front Immunol; 2023; 14():1089809. PubMed ID: 36776858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated miRNA Inversely Correlates with
    Guz M; Dworzański T; Jeleniewicz W; Cybulski M; Kozicka J; Stepulak A; Celiński K
    Biomed Res Int; 2020; 2020():4250329. PubMed ID: 32775420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients.
    Valmiki S; Ahuja V; Paul J
    World J Gastroenterol; 2017 Aug; 23(29):5324-5332. PubMed ID: 28839432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncomir MicroRNA-346 Is Upregulated in Colons of Patients With Primary Sclerosing Cholangitis.
    Kempinska-Podhorodecka A; Blatkiewicz M; Wunsch E; Krupa L; Gutkowski K; Milkiewicz P; Milkiewicz M
    Clin Transl Gastroenterol; 2020 Jan; 11(1):e00112. PubMed ID: 31972611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
    Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
    Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circCCDC9 acts as a miR-6792-3p sponge to suppress the progression of gastric cancer through regulating CAV1 expression.
    Luo Z; Rong Z; Zhang J; Zhu Z; Yu Z; Li T; Fu Z; Qiu Z; Huang C
    Mol Cancer; 2020 May; 19(1):86. PubMed ID: 32386516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.